GHK-Cu Research Overview: Topical vs Injected Studies
GHK is a three-amino-acid peptide, glycyl-L-histidyl-L-lysine, first reported in 1973 as a factor in human serum that prolonged the survival of normal liver cells in culture (Pickart 1973). It binds copper(II) very strongly, and the copper complex is known as GHK-Cu. The same three-residue sequence appears inside the alpha-2 chain of type I collagen, which led researchers to suggest it may be released locally when collagen is broken down at a wound site (Maquart 1988).
Studied Mechanisms
- Collagen synthesis — in fibroblast cultures, GHK-Cu increased collagen production starting at very low concentrations (10−12 to 10−11 M), with the largest effect at 10−9 M, and without a change in cell number (Maquart 1988).
- Gene expression — a study of lung tissue from people with COPD used a gene-expression database (the Connectivity Map) to look for compounds that reverse the gene pattern linked to emphysema. GHK was one of them. In human lung fibroblasts, GHK shifted gene expression toward TGF-β pathway activity, reorganized the actin skeleton, and restored collagen gel contraction by fibroblasts from COPD lungs (Campbell 2012).
- Inflammatory signalling — in macrophages and in mice with LPS-induced lung injury, GHK-Cu reduced reactive oxygen species and the inflammatory signals TNF-α and IL-6, through suppression of the NF-κB p65 and p38 MAPK pathways (Park 2016).
Two broad reviews of GHK gene-expression data were written by the peptide's original discoverer (Pickart 2015; Pickart 2018). They are useful maps of the field, but much of the gene data they draw on comes from database analysis rather than direct experiments.
Topical vs Injected: What Each Kind of Study Looked At
GHK-Cu is studied by two very different routes, and the questions each route answers are different. Results from one route should not be assumed to carry over to the other.
Topical studies (applied to skin)
- Skin penetration in the lab — using human skin in diffusion cells, copper applied as the GHK-Cu complex passed through dermatomed skin over 48 hours, and part of it stayed in the skin as a reservoir. Note that this study measured copper, not the intact peptide (Hostynek 2011). An earlier study using a liposome membrane that models the skin's outer lipid layer also found that copper-peptide complexes cross it (Mazurowska 2008).
- Animal wound models — in rats with ischemic open wounds, a topical GHK-Cu gel reduced wound area to a greater degree than either the gel base alone or no treatment (64.5% vs 45.6% vs 28.2% reduction by day 13), with lower TNF-α and MMP-2 and MMP-9 levels in the wounds (Canapp 2003).
- Controlled human studies — results have been mixed. In a randomized, evaluator-blinded trial in 86 patients with venous leg ulcers, a GHK-Cu cream did not differ from an inert placebo cream, while a silver sulfadiazine cream did reduce ulcer size (Bishop 1992). In a small randomized study of 13 patients after CO2 laser skin resurfacing, products with GHK-Cu made no measurable difference to redness, wrinkles or skin quality on blinded assessment, although patients in the GHK-Cu group reported higher satisfaction on a questionnaire (Miller 2006).
Injected studies (animal models)
- Acute lung injury — mice given GHK-Cu by intraperitoneal injection before an LPS lung challenge showed less lung tissue damage and less inflammatory-cell infiltration than controls (Park 2016).
- Lung fibrosis — two mouse studies of bleomycin-induced lung fibrosis reported that GHK (Zhou 2017) and GHK-Cu (Ma 2020) reduced fibrosis markers, through TGF-β1/Smad signalling and oxidative-stress and inflammation pathways respectively.
- Human data — a PubMed search in October 2026 found no published clinical trials of injected GHK-Cu in people. Injected-route research is so far limited to animal and cell models.
Handling in the Lab
GHK-Cu is supplied as a lyophilized powder that is typically blue to violet, a colour that comes from the bound copper. Unopened vials are best stored at −20 °C, protected from light and moisture. After reconstitution, keep the solution at 2–8 °C and avoid repeated freeze–thaw cycles. Our reconstitution guide and Reconstitution Calculator cover the concentration math.
See the GHK-Cu product page for current batch specifications.
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-7. PubMed 4349963
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. PubMed 3169264
- Campbell JD, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PubMed 22937864
- Park JR, et al. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405-17. PubMed 27517151
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PubMed 26236730
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520
- Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86. PubMed 20721598
- Mazurowska L, Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. J Cosmet Sci. 2008;59(1):59-69. PubMed 18350235
- Canapp SO Jr, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. PubMed 14648529
- Bishop JB, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg. 1992;16(2):251-7. PubMed 1495150
- Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9. PubMed 16847171
- Zhou XM, et al. GHK peptide inhibits bleomycin-induced pulmonary fibrosis in mice by suppressing TGFβ1/Smad-mediated epithelial-to-mesenchymal transition. Front Pharmacol. 2017;8:904. PubMed 29311918
- Ma WH, et al. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Life Sci. 2020;241:117139. PubMed 31809714